Atrophic Remodeling of the Heart In Vivo Simultaneously Activates Pathways of Protein Synthesis and Degradation
- 18 November 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 108 (20) , 2536-2541
- https://doi.org/10.1161/01.cir.0000096481.45105.13
Abstract
Background— Mechanical unloading of the heart results in atrophic remodeling. In skeletal muscle, atrophy is associated with inactivation of the mammalian target of rapamycin (mTOR) pathway and upregulation of critical components of the ubiquitin proteosome proteolytic (UPP) pathway. The hypothesis is that mechanical unloading of the mammalian heart has differential effects on pathways of protein synthesis and degradation. Methods and Results— In a model of atrophic remodeling induced by heterotopic transplantation of the rat heart, we measured gene transcription, protein expression, polyubiquitin content, and regulators of the mTOR pathway at 2, 4, 7, and 28 days. In atrophic hearts, there was an increase in polyubiquitin content that peaked at 7 days and decreased by 28 days. Furthermore, gene and protein expression of UbcH2, a ubiquitin conjugating enzyme, was also increased early in the course of unloading. Transcript levels of TNF-α, a known regulator of UbcH2-dependent ubiquitin conjugating activity, were upregulated early and transiently in the atrophying rat heart. Unexpectedly, p70S6K and 4EBP1, downstream components of mTOR, were activated in atrophic rat heart. This activation was independent of Akt, a known upstream regulator of mTOR. Rapamycin treatment of the unloaded rat hearts inhibited the activation of p70S6K and 4EBP1 and subsequently augmented atrophy in these hearts compared with vehicle-treated, unloaded hearts. Conclusions— Atrophy of the heart, secondary to mechanical unloading, is associated with early activation of the UPP. The simultaneous activation of the mTOR pathway suggests active remodeling, involving both protein synthesis and degradation.Keywords
This publication has 21 references indexed in Scilit:
- Regulation of targets of mTOR (mammalian target of rapamycin) signalling by intracellular amino acid availabilityBiochemical Journal, 2003
- TNF‐α increases ubiquitin‐conjugating activity in skeletal muscle by up‐regulating UbcH2/E220kThe FASEB Journal, 2003
- Rapamycin Attenuates Load-Induced Cardiac Hypertrophy in MiceCirculation, 2003
- Mammalian Target of Rapamycin and Protein Kinase A Signaling Mediate the Cardiac Transcriptional Response to GlutamineJournal of Biological Chemistry, 2003
- A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specificationProceedings of the National Academy of Sciences, 2002
- Identification of Ubiquitin Ligases Required for Skeletal Muscle AtrophyScience, 2001
- Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophyNature Medicine, 1998
- Muscle wasting in a rat model of long-lasting sepsis results from the activation of lysosomal, Ca2+ -activated, and ubiquitin-proteasome proteolytic pathways.Journal of Clinical Investigation, 1996
- RAPAMYCIN, A POTENT IMMUNOSUPPRESSIVE DRUG FOR VASCULARIZED HEART, KIDNEY, AND SMALL BOWEL TRANSPLANTATION IN THE RATTransplantation, 1991
- Biochemical consequences of protein depletion in the rabbit heartJournal of Surgical Research, 1987